• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects of chronic phencyclidine on fixed-ratio responding: no relation to neurotransmitter receptor binding in rat cerebral cortex.

作者信息

Schwartz R D, Moerschbaecher J M, Thompson D M, Kellar K J

出版信息

Pharmacol Biochem Behav. 1982 Apr;16(4):647-52. doi: 10.1016/0091-3057(82)90431-2.

DOI:10.1016/0091-3057(82)90431-2
PMID:6280207
Abstract

The effects of chronic phencyclidine (3.2 mg/kg for 25 days) on responding maintained under a fixed-ratio 30 schedule of food presentation were studied in rats. Initially phencyclidine produced large decreases in the overall rate of responding. This decrease was due primarily to long pauses in responding and secondarily to a decrease in local rates of responding. Although tolerance developed to the rate-decreasing effects of phencyclidine in each subject, the extent and pattern of its development differed among the subjects. After the chronic drug regimen, the rats were sacrificed. Ligand binding to muscarinic cholinergic, opiate, adrenergic, and serotonergic receptors in cortex was then compared to that in rats which received saline with operant training, phencyclidine alone, or saline alone. Neither operant behavior alone, phencyclidine alone, nor the interaction of phencyclidine and operant behavior was found to alter binding to these receptors. These results indicate that behavioral tolerance develops to phencyclidine, but it is not accompanied by changes in binding to the receptors studied.

摘要

相似文献

1
Effects of chronic phencyclidine on fixed-ratio responding: no relation to neurotransmitter receptor binding in rat cerebral cortex.
Pharmacol Biochem Behav. 1982 Apr;16(4):647-52. doi: 10.1016/0091-3057(82)90431-2.
2
Effects of terminating chronic phencyclidine on schedule-controlled behavior in rats.
Pharmacol Biochem Behav. 1990 May;36(1):117-21. doi: 10.1016/0091-3057(90)90135-5.
3
Situational specificity of tolerance to effects of phencyclidine on responding of rats under fixed-ratio and spaced-responding schedules.苯环利定对大鼠在固定比率和间隔反应程序下反应的耐受性的情境特异性。
Psychopharmacology (Berl). 1991;103(1):121-8. doi: 10.1007/BF02244086.
4
Effects of phencyclidine, haloperidol, and naloxone on fixed-interval performance in rats.苯环利定、氟哌啶醇和纳洛酮对大鼠固定间隔行为表现的影响。
Psychopharmacology (Berl). 1984;84(1):32-8. doi: 10.1007/BF00432020.
5
Effects of phencyclidine, d-amphetamine and pentobarbital on schedule-controlled behavior in rats.苯环利定、右旋苯丙胺和戊巴比妥对大鼠按程序控制行为的影响。
Pharmacol Biochem Behav. 1981 Nov;15(5):807-12. doi: 10.1016/0091-3057(81)90026-5.
6
d-Amphetamine and phencyclidine alone and in combination: effects on fixed-ratio and interresponse-time-greater-than-t responding of rats.右旋苯丙胺和苯环利定单独及联合使用:对大鼠固定比率和反应间隔时间大于T反应的影响。
Pharmacol Biochem Behav. 1981 Sep;15(3):357-61. doi: 10.1016/0091-3057(81)90262-8.
7
Tolerance to the behavioral effects of phencyclidine: the importance of behavioral and pharmacological variables.对苯环己哌啶行为效应的耐受性:行为和药理学变量的重要性。
Psychopharmacology (Berl). 1979 Jun 28;64(1):19-24. doi: 10.1007/BF00427339.
8
Chronic phencyclidine treatment decreases phencyclidine and dopamine receptors in rat brain.长期给予苯环己哌啶会降低大鼠脑中的苯环己哌啶和多巴胺受体。
Pharmacol Biochem Behav. 1982 Oct;17(4):699-702. doi: 10.1016/0091-3057(82)90349-5.
9
Tolerance following the repeated administration of high doses of phencyclidine: no relation to central catecholamine depletion.重复给予高剂量苯环利定后的耐受性:与中枢儿茶酚胺耗竭无关。
Drug Alcohol Depend. 1984 May;13(3):225-34. doi: 10.1016/0376-8716(84)90063-2.
10
Discriminative stimulus properties of ketamine stereoisomers in phencyclidine-trained rats.氯胺酮立体异构体在苯环己哌啶训练大鼠中的辨别刺激特性。
Pharmacol Biochem Behav. 1982 Aug;17(2):291-5. doi: 10.1016/0091-3057(82)90083-1.